HIF-Prolyl Hydroxylase 2 Inhibition Enhances the Efficiency of Mesenchymal Stem Cell-Based Therapies for the Treatment of Critical Limb Ischemia
about
Genetic Engineering of Mesenchymal Stem Cells to Induce Their Migration and SurvivalPHD2: from hypoxia regulation to disease progressionNanovector-based prolyl hydroxylase domain 2 silencing system enhances the efficiency of stem cell transplantation for infarcted myocardium repair.Dimethyloxaloylglycine Promotes the Angiogenic Activity of Mesenchymal Stem Cells Derived from iPSCs via Activation of the PI3K/Akt Pathway for Bone Regeneration.Metabolic regulation of mesenchymal stem cell in expansion and therapeutic application.Prolyl hydroxylase inhibitors act as agents to enhance the efficiency of cell therapy.Stem cell therapy for the systemic right ventricle.Conjugation of palmitic acid improves potency and longevity of siRNA delivered via endosomolytic polymer nanoparticles.Donor-dependent variation of human umbilical cord blood mesenchymal stem cells in response to hypoxic preconditioning and amelioration of limb ischemia.HIF-P4H-2 deficiency protects against skeletal muscle ischemia-reperfusion injury.Stabilization of Hypoxia-Inducible Factor-1 Alpha Augments the Therapeutic Capacity of Bone Marrow-Derived Mesenchymal Stem Cells in Experimental Pneumonia.Stem-Cell-Based Therapies for Vascular Regeneration in Peripheral Artery Diseases
P2860
Q26744561-05394F7C-8CDE-4860-B7D0-0453C2190B86Q28069316-EB28B742-9DB5-4B8C-BB69-C42E40D284ABQ30601810-9A37A846-9DF7-4A09-A33A-8DDE79CA54CBQ36911067-E1E87A55-9EEF-42F6-A8F5-11F4E2000DA8Q38287785-E7C28682-33B2-4135-8589-4E652549284AQ38577907-B41B5BD2-0916-498A-B8C6-A125AEE362D1Q41997705-2C433ABF-2FE0-4DB3-832C-AF788895B8DEQ42408555-657E3DC2-F93D-48CA-84C9-98B90541AFBDQ52718163-F9600029-6006-494C-AD5B-6A17D9AACC6DQ53317012-81DCCC76-A6B8-4A49-B39A-1EAC063609FBQ55362919-CDC5F2B6-53DE-4A8C-A2B7-5064B84100BBQ57767168-77F216E9-E4E4-4E73-9415-5204B8F51011
P2860
HIF-Prolyl Hydroxylase 2 Inhibition Enhances the Efficiency of Mesenchymal Stem Cell-Based Therapies for the Treatment of Critical Limb Ischemia
description
im Jahr 2014 veröffentlichter wissenschaftlicher Artikel
@de
wetenschappelijk artikel
@nl
наукова стаття, опублікована в січні 2014
@uk
name
HIF-Prolyl Hydroxylase 2 Inhib ...... ment of Critical Limb Ischemia
@en
HIF-Prolyl Hydroxylase 2 Inhib ...... ment of Critical Limb Ischemia
@nl
type
label
HIF-Prolyl Hydroxylase 2 Inhib ...... ment of Critical Limb Ischemia
@en
HIF-Prolyl Hydroxylase 2 Inhib ...... ment of Critical Limb Ischemia
@nl
prefLabel
HIF-Prolyl Hydroxylase 2 Inhib ...... ment of Critical Limb Ischemia
@en
HIF-Prolyl Hydroxylase 2 Inhib ...... ment of Critical Limb Ischemia
@nl
P2093
P2860
P50
P356
P1433
P1476
HIF-Prolyl Hydroxylase 2 Inhib ...... ment of Critical Limb Ischemia
@en
P2093
Bernard I. Lévy
Clément D'Audigier
Coralie L. Guérin
Céline Loinard
Joseph Emmerich
Kiave-Yune HoWangYin
Wineke Bakker
P2860
P304
P356
10.1002/STEM.1540
P50
P577
2014-01-01T00:00:00Z